240 related articles for article (PubMed ID: 6777578)
1. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
[No Abstract] [Full Text] [Related]
2. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
[No Abstract] [Full Text] [Related]
3. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
4. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E
Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210
[No Abstract] [Full Text] [Related]
5. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
[No Abstract] [Full Text] [Related]
6. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
[No Abstract] [Full Text] [Related]
7. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
[No Abstract] [Full Text] [Related]
8. [Pseudomonas multicomponent vaccine in major burn patients].
Mizuno H; Ashikawa K
Nihon Rinsho; 1991 Oct; 49(10):2425-30. PubMed ID: 1749100
[No Abstract] [Full Text] [Related]
9. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine.
Pranter W; Staerk J; Zellner R; Zwisler O
Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968
[No Abstract] [Full Text] [Related]
10. [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].
Kolker II; Stanislavskiĭ ES; Grishina IA; Panova IuM; Krokhina MA
Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):29-33. PubMed ID: 6784114
[No Abstract] [Full Text] [Related]
11. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
Baumann U; Mansouri E; von Specht BU
Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients.
Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J
Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426
[No Abstract] [Full Text] [Related]
13. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
Moroz AF; Kharitonova AM; Chanturiia TsK
Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
[TBL] [Abstract][Full Text] [Related]
14. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
Meitert E; Meitert T; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
[No Abstract] [Full Text] [Related]
15. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
[No Abstract] [Full Text] [Related]
16. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
Zellner PR; Zwissler O; Metzger E
Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa: prevention better than cure?
Mellor JA; Miler JJ
Dev Biol Stand; 1979; 43():53-9. PubMed ID: 118071
[TBL] [Abstract][Full Text] [Related]
18. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
Kawaharajo K; Homma JY
Jpn J Exp Med; 1977 Dec; 47(6):495-500. PubMed ID: 416253
[TBL] [Abstract][Full Text] [Related]
19. Controlled trials of a polyvalent pseudomonas vaccine in burns.
Jones RJ; Roe EA; Gupta JL
Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
[TBL] [Abstract][Full Text] [Related]
20. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine.
Sachs A
Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971
[No Abstract] [Full Text] [Related]
[Next] [New Search]